Erez Chimovits
Director at ADARx Pharmaceuticals, Inc. (ADRX); Director at Braveheart Bio, Inc. (BRVE)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys+$4.0M
Total bought / sold$36.0M / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 30SEC | ADRXADARx Pharmaceuticals, Inc. | Buy | 61,5169,292,025 held (+1%) | $17.00 | $1.0M | +4.6% |
| Aug 11SEC | BRVEBraveheart Bio, Inc. | Buy | 1,666,66711,901,826 held (+16%) | $18.00 | $30.0M | +11.2% |
| Aug 11SEC | BRVEBraveheart Bio, Inc. | Buy | 273,333new position | $18.00 | $4.9M | +11.2% |
- Buy
Director Erez Chimovits bought $1.0M of ADRX at $17.00 — first open-market purchase in our records.
- Buy
Director Erez Chimovits bought $30.0M of BRVE at $18.00 — first open-market purchase in our records.
- Buy
Director Erez Chimovits bought $4.9M of BRVE at $18.00 — opens a new position.